ProQR Therapeutics N.V. Ordinary Shares (PRQR) is a publicly traded Healthcare sector company. As of July 13, 2026, PRQR trades at $1.73 with a market cap of $244.14M and a P/E ratio of 0.00. PRQR moved +0.29% today. Year to date, PRQR is -13.50%; over the trailing twelve months it is -26.69%. Its 52-week range spans $1.07 to $3.97. Analyst consensus is strong buy with an average price target of $8.67. Rallies surfaces PRQR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for PRQR shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $1.73 |
| Market Cap | $244.14M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.97 |
| 52-Week Low | $1.07 |
| Volume | 348.24K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
6 analysts cover PRQR: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $8.67.